News | October 11, 2024
OneSource unveils new brand identity at CPHI Milan
Aims to achieve CDMO sales of US$ 400 million by 2028
Aims to achieve CDMO sales of US$ 400 million by 2028
Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
The inspection closed with five observations which were more of procedural changes with none of these related to data integrity
Subscribe To Our Newsletter & Stay Updated
